Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal

NCT05808192 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.

NCT NCT05808192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05808192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal
Lead sponsor
University of Rome Tor Vergata
Phase
Observational
Overall status
Completed
Start date
September 1, 2020
Completion date
May 1, 2022
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

5 years of follow-up after transplant, in which an attempt was made to suspend is, single transplant